These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24127871)

  • 21. Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response.
    Kimizuka Y; Katagiri W; Locascio JJ; Shigeta A; Sasaki Y; Shibata M; Morse K; Sîrbulescu RF; Miyatake M; Reeves P; Suematsu M; Gelfand J; Brauns T; Poznansky MC; Tsukada K; Kashiwagi S
    J Immunol; 2018 Dec; 201(12):3587-3603. PubMed ID: 30420435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tailored immunity by skin antigen-presenting cells.
    Levin C; Perrin H; Combadiere B
    Hum Vaccin Immunother; 2015; 11(1):27-36. PubMed ID: 25483512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivering vaccines into the skin without needles and syringes.
    Partidos CD
    Expert Rev Vaccines; 2003 Dec; 2(6):753-61. PubMed ID: 14711359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of an Immune Regulation Technology Targeting the Skin and Promotion of the Practical Applications of Transcutaneous Vaccination/Immunotherapy].
    Okada N
    Yakugaku Zasshi; 2019; 139(9):1129-1137. PubMed ID: 31474627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Particle-based vaccines for transcutaneous vaccination.
    Combadière B; Mahé B
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):293-315. PubMed ID: 17915323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
    Denis F; Alain S; Ploy MC
    Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micro-fractional Epidermal Powder Delivery for Skin Vaccination.
    Jia F; Liu S; Wu MX; Chen X
    Methods Mol Biol; 2016; 1404():715-723. PubMed ID: 27076332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin.
    Glenn GM; Kenney RT; Ellingsworth LR; Frech SA; Hammond SA; Zoeteweij JP
    Expert Rev Vaccines; 2003 Apr; 2(2):253-67. PubMed ID: 12899576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination.
    Sun X; Zeng L; Huang Y
    J Gene Med; 2019 Jul; 21(7):e3089. PubMed ID: 30958606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy.
    Hammond SA; Guebre-Xabier M; Yu J; Glenn GM
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):503-26. PubMed ID: 11763499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticulate mediated transcutaneous immunization: Myth or reality.
    Kaurav M; Minz S; Sahu K; Kumar M; Madan J; Pandey RS
    Nanomedicine; 2016 May; 12(4):1063-1081. PubMed ID: 26767517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcutaneous and intradermal vaccination.
    Combadiere B; Liard C
    Hum Vaccin; 2011 Aug; 7(8):811-27. PubMed ID: 21817854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal immune responses induced by transcutaneous vaccines.
    Lawson LB; Clements JD; Freytag LC
    Curr Top Microbiol Immunol; 2012; 354():19-37. PubMed ID: 22435116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
    Machado Y; Duinkerken S; Hoepflinger V; Mayr M; Korotchenko E; Kurtaj A; Pablos I; Steiner M; Stoecklinger A; Lübbers J; Schmid M; Ritter U; Scheiblhofer S; Ablinger M; Wally V; Hochmann S; Raninger AM; Strunk D; van Kooyk Y; Thalhamer J; Weiss R
    J Control Release; 2017 Nov; 266():87-99. PubMed ID: 28919557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
    Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010720. PubMed ID: 30091147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Progress in Particle-Based Systems for Transdermal Vaccine Delivery.
    Pielenhofer J; Sohl J; Windbergs M; Langguth P; Radsak MP
    Front Immunol; 2020; 11():266. PubMed ID: 32174915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
    An M; Liu H
    Small; 2017 Jul; 13(26):. PubMed ID: 28544329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.